All stock lists
Continental Aktiengesellschaft (Deutsche Börse:CON.DE)
DE · Delayed Price · Currency is EUR
Also listed: CTTAFConsumer Cyclical · Auto - Parts
67.40+0.86 (+1.29%)
Market cap
$13.5B
Health Score
Analyst consensus
Listed since
Dec 16, 1996
Website
Insider Score
––Not scored
CON.DE Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Sound
From CON.DE’s reported statements · Q2 2026 (trailing 12 months)
Profitability9 / 20
Loses money on what it sells.
- Revenue
- $17.63B
- Net income
- -$265.0M
- Net margin
- -1.5%
Leverage4 / 20
Heavily indebted for what it earns.
- Total debt
- $6.88B
- Cash
- $815.0M
- Net debt / EBITDA
- 3.12x
Liquidity12 / 20
Covers near-term obligations, without much room.
- Current assets
- $11.17B
- Current liabilities
- $8.07B
- Current ratio
- 1.38
Cash generation17 / 20
The business funds itself from operations.
- Operating cash flow
- $2.53B
- Free cash flow
- $1.58B
- FCF margin
- 9.0%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 200.0M
- Share growth (1y)
- 0.0%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
CON.DE Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 3.32 B | 4.40 B | 4.96 B | 4.95 B | 4.86 B | 4.91 B |
| Revenue Growth (YoY) | -31.63 % | -10.38 % | -50.82 % | -0.88 % | -2.82 % | 0.12 % |
| Cost of Revenue | 2.22 B | 3.10 B | 3.70 B | 3.63 B | 3.62 B | 3.62 B |
| Gross Profit | 1.10 B | 1.29 B | 1.26 B | 1.32 B | 1.24 B | 1.28 B |
| SG&A Expense | 554.00 M | 679.00 M | 822.00 M | 722.00 M | 743.00 M | 713.00 M |
| R&D Expense | 97.00 M | 133.00 M | 130.00 M | 144.00 M | 139.00 M | 149.00 M |
| Operating Expenses | 650.00 M | 802.00 M | 971.00 M | 866.00 M | 882.00 M | 862.00 M |
| Operating Income | 446.00 M | 490.00 M | 293.00 M | 458.00 M | 357.00 M | 422.00 M |
| Pretax Income | 323.00 M | 327.00 M | 138.00 M | -773.00 M | 262.00 M | 342.00 M |
| Tax Provision | 88.00 M | 136.00 M | 121.00 M | 167.00 M | -40.00 M | 135.00 M |
| Net Income | 274.00 M | 200.00 M | 17.00 M | -756.00 M | 506.00 M | 68.00 M |
| EPS (Basic) | 1.37 | 1.00 | 0.09 | -3.78 | 2.53 | 0.34 |
| EPS (Diluted) | 1.37 | 1.00 | 0.09 | -3.78 | 2.53 | 0.34 |
| Shares Outstanding | 200.00 M | 200.01 M | 200.00 M | 200.00 M | 200.00 M | 200.00 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
